Aurobindo Pharma Ltd Quarterly Results

Gross Sales

8,236.96

7,791.77

8,381.12

7,893.15

7,646.21

Excise Duty

0

0

0

0

0

Net Sales

8,236.96

7,791.77

8,381.12

7,893.15

7,646.21

Other Operating Income

48.74

76.37

1

85.37

149.86

Other Income

122.25

107.22

134.81

158.88

136.3

Total Income

8,407.95

7,975.36

8,516.93

8,137.4

7,932.37

Total Expenditure

6,607.6

6,265.11

6,622.39

6,400.54

6,229.93

PBIDT

1,800.35

1,710.25

1,894.54

1,736.86

1,702.44

Interest

95.24

97.75

115.02

118.48

112.7

PBDT

1,705.11

1,612.5

1,779.52

1,618.38

1,589.74

Depreciation

429.19

405.7

444.43

418.53

382.28

Minority Interest Before NP

0

0

0

0

0

Tax

463.03

490.72

430.51

498.07

322.13

Deferred Tax

-35.24

-108.12

1.75

-143.79

68.38

Reported Profit After Tax

848.13

824.2

902.83

845.57

816.95

Minority Interest After NP

-0.32

-0.55

-0.64

-0.24

-0.43

Net Profit after Minority Interest

848.45

824.75

903.47

845.81

817.38

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

848.45

824.75

903.47

845.81

817.38

EPS (Unit Curr.)

14.61

14.2

15.56

14.56

14

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

400

0

0

0

Equity

58.08

58.08

58.08

58.08

58.08

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

21.85

21.94

22.6

22

22.26

PBDTM(%)

20.7

20.69

21.23

20.5

20.79

PATM(%)

10.29

10.57

10.77

10.71

10.68